Are COVID-19 Vaccine Babies Toddling and Babbling Normally?

Preclinical Studies Predict Neurodevelopmental Problems

By Peter A. McCullough, MD, MPH

The rush to mass vaccinate the world with genetic vaccines launched in 2021 with a reckless hubris that will go down in history. With no assurances on safety or efficacy, the American College of Obstetrics and Gynecology broke the time-honored conservative stance on novel products in pregnant women and broadly endorsed the shots that skipped all preclinical and clinical testing during gestation.

Now years later, scientists are filling in the knowledge gaps, and in the case of a rat study by Erdogan et al, with results that are making many in the clinical community uncomfortable. In short, they found that pregnant rats injected with the Pfizer BNT162b2 vaccine had male progeny in particular, that tended to have concordant neurodegenerative changes with impaired behaviors on standardized testing.

“In conclusion, our study presents evidence that the COVID-19 mRNA BNT162b2 vaccine impacts the Wnt pathway (one of the most crucial morphogens in development and during the maturation of central nervous system) and brain-derived neurotrophic factor [BDNF] levels in rats, with particularly pronounced effects observed in males. These male-specific outcomes, including autism-like behaviors, reduced neuronal counts, and impaired motor performance, emphasize the potential neurodevelopmental implications of the vaccine, aligning with existing literature on the roles of the WNT pathway and BDNF signaling in neurodevelopmental disorders.”